Maintaining a reliable cold chain is essential for temperature-sensitive goods. WarmMark QR, a battery-free, QR-enabled temperature sensor simplifies cold chain monitoring by providing affordable, real-time and package-level temperature visibility. By embracing a modern digital solution, it eliminates the interpretation errors of visual indicators, promotes recipient adoption and enables remote data access for shippers. For industries like life sciences and pharmaceuticals whose product integrity depends on temperature consistency, WarmMark QR is providing greater accountability and operational efficiency across the supply chain.
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.
Lisata Therapeutics acquires Marea Therapeutics and secures $225 million in concurrent financing, while mAbxience and Sandoz partner to develop and globally commercialize an emicizumab biosimilar.
Former Rep. Joe Cunningham (D-SC), now spokesperson for the Pharmaceutical Reform Alliance, argues that codifying Most-Favored-Nation pricing into law is the real fix for drug costs.
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument against MFN pricing.
